As part of NCI’s ongoing Cancer Moonshot program, the institute, NIH and 11 biopharmaceutical companies launched a five-year public-private research collaboration Oct. 12 designed to advance new immunotherapy treatments.
For a year before an osteosarcoma was found in her right proximal tibia, Sammy Ulloa, pushing through pain, persisted with her training as a Division I track and field and cross-country competitor.
